This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Vladimir Hachinski, MD, FRCP(C)

Arch Neurol. 1988;45(6):670.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Few diseases fluctuate as much as multiple sclerosis. This makes not only treatment but assessment difficult. Nevertheless, evidence from clinical, imaging, and cerebrospinal fluid studies¹ support Professor Compston's findings and conclusions that highdose intravenously administered methylprednisolone shortens the course of acute exacerbations and relieves spasticity in chronic cases. Professor Compston states that this represents only a modest advance in the treatment of multiple sclerosis. A little is a lot where there is little else.

Reference . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?